Key result
Combining RAS blockade with dietary salt restriction targets core drivers of salt-sensitive hypertension.
This review summarizes pathophysiological evidence establishing that salt-sensitive hypertension is mediated by renin-angiotensin system and sympathetic activation, thereby underscoring the clinical necessity of concomitant salt restriction during antihypertensive therapy with RAS inhibitors.
Supports combining RAS blockade with salt restriction in salt-sensitive hypertension; hypothesis-generating pending randomized trials.
Hypertension is still one of the major causes of death from cardiovascular failure. Increased salt intake may aggravate the rise in blood pressure and the development of consequential damage of the heart, the vessels and other organs. The general necessity of restricted salt intake regardless of blood pressure or salt sensitivity has been a matter of debate over the past decades. This review summarizes the main pathogenic mechanisms of hypertension and salt sensitivity in rat models, particularly in the spontaneously hypertensive rat (SHR), and in patients with essential hypertension (EH). Although SHRs are commonly considered to be salt-resistant, there is much evidence that salt loading may deteriorate blood pressure and cardiovascular function even in these animals. Similarly, EH is not a homogenous disorder - some patients, but not all, exhibit pronounced salt sensitivity. The renin-angiotensin system (RAS) plays a key role in the regulation of blood pressure and salt and fluid homeostasis and thus is one of the main targets of antihypertensive therapy. This review focuses on the contribution of the RAS to the pathogenesis of salt-sensitive hypertension in SHRs and patients with EH.
No takes yet. Share an insight, caveat, or question.
Beate Raßler (2010) conducted a review in Salt-sensitive essential hypertension. Renin-angiotensin system (RAS) antagonists and salt restriction was evaluated. The renin-angiotensin system plays a central role in the pathogenesis of salt-sensitive hypertension, highlighting the therapeutic importance of combining RAS blockade with dietary salt restriction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: